Literature DB >> 30128008

Distribution of circulating follicular helper T cells and expression of interleukin-21 and chemokine C-X-C ligand 13 in gastric cancer.

Xinying Meng1, Xinjuan Yu2, Quanjiang Dong2,3, Xiaona Xu2, Jinghua Li2, Qianqian Xu1, Jian Ma1, Changhong Zhou1.   

Abstract

Circulating follicular helper T (cTfh) cells are a novel subset of cluster of differentiation (CD)4+ helper T cells. Interleukin (IL)-21 and C-X-C motif chemokine ligand (CXCL)13 are the principal effectors and chemotactic regulatory factors of Tfh. However, the roles of IL-21 and CXCL13 in gastric cancer have not yet been completely elucidated. The aim of the present study was to investigate the distribution of cTfh cells, and the expression of IL-21 and CXCL13 in patients with gastric cancer was evaluated in order to ascertain the significance and potential mechanisms of these effectors in gastric cancer. A total of 50 patients with gastric cancer were enrolled as the study subjects, with 30 healthy individuals selected as controls. The percentage of cTfh cells (cTfh%) in the peripheral blood was calculated using flow cytometry. They are identified in the present study as CD4+ chemokine C-X-C receptor (CXCR)5+ inducible T cell co-stimulator (ICOS)+ cells. The serum levels of IL-21 and CXCL13 were determined by ELISA. The cTfh% in the peripheral blood and the concentration of IL-21 and CXCL13 in the serum were significantly higher in patients with gastric cancer compared with the control group. cTfh% was significantly higher in patients with lymph node metastasis, Tumor-Node-Metastasis (TNM) stage III-IV and low differentiation. The concentrations of IL-21 and CXCL13 in patients with lymph node metastasis and/or TNM III-IV were significantly higher than in those without lymph node metastasis or with TNM I-II. There was a positive correlation between cTfh%/CXCL13 and IL-21/CXCL13, while there was no correlation between cTfh%/IL-21. cTfh cells and associated factors (IL-21/CXCL13) may be involved in the development and progression of gastric cancer. There may be mutual regulation among cTfh cells, IL-21 and CXCL13.

Entities:  

Keywords:  chemokine C-X-C ligand 13; circulating; follicular helper T cells; gastric cancer; interleukin-21

Year:  2018        PMID: 30128008      PMCID: PMC6096128          DOI: 10.3892/ol.2018.9112

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  39 in total

1.  Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help.

Authors:  Svenja Hardtke; Lars Ohl; Reinhold Förster
Journal:  Blood       Date:  2005-05-17       Impact factor: 22.113

2.  Circulating follicular helper T cells in Crohn's disease (CD) and CD-associated colorectal cancer.

Authors:  Zhenlong Wang; Zhiming Wang; Yanqing Diao; Xiaoli Qian; Nan Zhu; Wen Dong
Journal:  Tumour Biol       Date:  2014-06-19

3.  Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis.

Authors:  Zhaoliang Su; Yingkun Sun; Haitao Zhu; Yueqin Liu; Xin Lin; Huiling Shen; Jianguo Chen; Wenlin Xu; Huaxi Xu
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

4.  Circulating CXCR5+CD4+ T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway.

Authors:  Zhanshan Cha; Guangfang Qian; Yan Zang; Haihui Gu; Yanyan Huang; Lishuang Zhu; Jinqi Li; Yang Liu; Xiaohua Tu; Haihan Song; Baohua Qian
Journal:  Exp Cell Res       Date:  2016-11-23       Impact factor: 3.905

5.  IL-21 and IL-12 inhibit differentiation of Treg and TH17 cells and enhance cytotoxicity of peripheral blood mononuclear cells in patients with cervical cancer.

Authors:  Yongju Tian; Cunzhong Yuan; Daoxin Ma; Yan Zhang; Yi Liu; Wenjing Zhang; Fei Hou; Baoxia Cui
Journal:  Int J Gynecol Cancer       Date:  2011-12       Impact factor: 3.437

6.  IL-21 gene polymorphism is associated with the prognosis of breast cancer in Chinese populations.

Authors:  Yonghe You; Jieqiong Deng; Jian Zheng; Min Hu; Na Li; Hongchun Wu; Wei Li; Jiachun Lu; Yifeng Zhou
Journal:  Breast Cancer Res Treat       Date:  2013-01-04       Impact factor: 4.872

Review 7.  IL-21: roles in immunopathology and cancer therapy.

Authors:  H Søndergaard; K Skak
Journal:  Tissue Antigens       Date:  2009-10-21

Review 8.  Interleukin 21: combination strategies for cancer therapy.

Authors:  Kresten Skak; Michael Kragh; Diana Hausman; Mark J Smyth; Pallavur V Sivakumar
Journal:  Nat Rev Drug Discov       Date:  2008-03       Impact factor: 84.694

9.  Downregulation of Hlx closely related to the decreased expressions of T-bet and Runx3 in patients with gastric cancer may be associated with a pathological event leading to the imbalance of Th1/Th2.

Authors:  Yan Xu; Jingjing Gao; Zhaoliang Su; Xiaoli Dai; Yazhen Li; Yingzhao Liu; Jianguo Chen; Jia Tong; Yun Zhang; Chaoyang Wu; Dong Zheng; Shengjun Wang; Huaxi Xu
Journal:  Clin Dev Immunol       Date:  2012-11-19

10.  Higher Frequency of CD4+CXCR5+ICOS+PD1+ T Follicular Helper Cells in Patients With Infectious Mononucleosis.

Authors:  Jinlin Liu; Yonglie Zhou; Qinghua Yu; Zhao Zhao; Huan Wang; Xiaoming Luo; Yanxia Chen; Zhongliang Zhu; Guoqing Chen; Mao Wu; Liannv Qiu
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more
  12 in total

Review 1.  Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm.

Authors:  Beverly R E A Dixon; Rafat Hossain; Rachna V Patel; Holly M Scott Algood
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

2.  Serum CXCL13 and PECAM-1 can be used as diagnostic and prognostic markers in elderly patients with gastric cancer.

Authors:  Y Li; X B Guo; Y H Wei; X L Kang
Journal:  Clin Transl Oncol       Date:  2020-06-04       Impact factor: 3.405

3.  CXCL13 Signaling in the Tumor Microenvironment.

Authors:  Muzammal Hussain; Jinsong Liu; Gui-Zhen Wang; Guang-Biao Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond.

Authors:  Marcelo G Kazanietz; Michael Durando; Mariana Cooke
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-12       Impact factor: 5.555

5.  Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma.

Authors:  Xinying Zhu; Xiaoli Xie; Qingchao Zhao; Lixian Zhang; Changjuan Li; Dongqiang Zhao
Journal:  Biomed Res Int       Date:  2020-06-26       Impact factor: 3.411

6.  Serum CXCL13 Level is Associated with Tumor Progression and Unfavorable Prognosis in Penile Cancer.

Authors:  Miao Mo; Shiyu Tong; Tao Li; Xiongbing Zu; Xiheng Hu
Journal:  Onco Targets Ther       Date:  2020-08-31       Impact factor: 4.147

7.  Comprehensive analysis of prognostic genes in gastric cancer.

Authors:  Shaohua Huang; Liping Ma; Biyang Lan; Ning Liu; Wenwei Nong; Zhihu Huang
Journal:  Aging (Albany NY)       Date:  2021-10-22       Impact factor: 5.682

Review 8.  Impact of Immunotherapy on CD4 T Cell Phenotypes and Function in Cancer.

Authors:  Margaux Saillard; Mara Cenerenti; Pedro Romero; Camilla Jandus
Journal:  Vaccines (Basel)       Date:  2021-05-04

9.  Association between interleukin-21 gene rs907715 polymorphism and gastric precancerous lesions in a Chinese population.

Authors:  Xiao-Qin Wang; Yang Li; Paul D Terry; Wen-Jing Kou; Yue Zhang; Zhao-Zhao Hui; Xiao-Han Ren; Ming-Xu Wang
Journal:  World J Gastrointest Oncol       Date:  2020-03-15

Review 10.  CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities.

Authors:  San-Hui Gao; Sheng-Zhi Liu; Gui-Zhen Wang; Guang-Biao Zhou
Journal:  Life (Basel)       Date:  2021-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.